Genetic Aspects Of Viral Oncogenesis In Wild Mouse Speci

Niaid Extramural Activities

Investigators

Linked publications & trials

Abstract

The various inbred laboratory mouse strains differ from one another and from wild mouse species in their susceptibility to the mouse gammaretroviruses and retrovirus-induced diseases. These differences are due to differences in specific host genes, and we have been engaged in an ongoing effort to identify and characterize several mouse genes involved in this resistance. Our major focus has been on cell surface virus receptors and cellular factors that interfere with receptor binding. One area of investigation focused on a novel virus resistance gene originally found in the Asian wild mouse species M. castaneus. This gene, termed Rmcf2, is responsible for partial resistance to the highly pathogenic polytropic class of leukemia viruses. We have now demonstrated that this resistance is due to a chromosomally integrated copy of the viral genome, and we have shown that expression of the envelope glycoprotein of this integrated provirus is associated with the virus resistance phenotype. This suggests that Rmcf2 resistance may be mediated through an interference mechanism. [unreadable] [unreadable] A second study deals with two unusual variants of the ecotropic gammaretroviruses that are cytopathic in M. dunni cells and also have altered host range. These phenotypes are due to different amino acid substitutions at the same site in the two viruses. This substitution alters one of the 3 amino acids that form the cell surface receptor binding site. The fact that these 2 viruses cause cytopathic effects in a cell line with a variant receptor gene suggests that the virus-receptor interaction mediates cytopathicity. This conclusion was confirmed by the observation that cytopathicity due to virus infection is seen in stable transfectants expressing this variant receptor but not in transfectants expressing the prototypical receptor. Because evidence also suggests that cytopathicity is affected by inhibitors of glycosylation, we are currently evaluating the role of glycosylation in virus infectivity and cytopathicity.[unreadable] [unreadable] In a third study, we have screened a panel of cells derived from evolutionarily divergent wild mouse species for infectivity with a panel of mouse gammaretroviruses. These cells show novel patterns of resistance. Analysis of one of these resistance phenotypes shows that the block to virus replication is post entry and targets the viral capsid. These cells are being evaluated for the presence of a novel allele at Fv1, a gene responsible for capsid-mediated resistance in laboratory mice. Additional resistance phenotypes identified in cells of other species are being characterized for polymorphisms of the cell surface receptors and for levels of receptor expression.